TY - JOUR
T1 - A Core Outcome Set for Patients with Chronic Symptomatic Peripheral Arterial Disease
AU - VASCUL-AID collaborators and expert consensus meeting collaborators
AU - Zwetsloot, Sabrina L.M.
AU - Rijken, Lotte
AU - Koncar, Igor
AU - Tomic, Ivan
AU - Dias-Neto, Marina
AU - Lee, Regent
AU - Tulamo, Riikka
AU - Behrendt, Christian Alexander
AU - Lareyre, Fabien
AU - Smit, Noeska N.
AU - Jongkind, Vincent
AU - Yeung, Kak Khee
AU - Wolterink, Jelter M.
AU - Išgum, Ivana
AU - Marquering, Henk A.
AU - Ploem, M. Corrette
AU - Catarinella, Fabio
AU - Bera, Kasia D.
AU - Buisan, Jenny
AU - Zhang, Ping
AU - Raffort, Juliette
AU - Muller, Catelijne
AU - Koncar, Igor
AU - Matejevic, David
AU - Živković, Maja
AU - Djuric, Tamara
AU - Stankovic, Aleksandra
AU - Venermo, Maarit
AU - Laivuori, Mirjami
AU - Schijven, Marlies P.
AU - van den Born, Bert J.H.
AU - Delewi, Ronak
AU - Smorenburg, Stefan P.M.
AU - Ayyalasomayajula, Venkat
AU - Bauersachs, Rupert
AU - Kauhanen, Petteri
AU - Noronen, Katariina
AU - Neves, João Rocha
AU - Barbosa, Cátia Martins
AU - Dias, Dinis Pereira
AU - Dias da Silva, Carlos
AU - Barbosa, João Silva
AU - Markovic, Miroslav
AU - Nio, Denise
AU - Warlé, Michiel
AU - Teeuw, Anna
AU - Nasr, Bahaa
N1 - Publisher Copyright:
© 2025 The Author(s)
PY - 2025
Y1 - 2025
N2 - Objective: Current literature on patients with peripheral arterial disease (PAD) is heterogeneous and characterised by selective outcome reporting. A core outcome set (COS) is a list of essential outcomes based on expert consensus used to standardise clinical research, reflecting the needs of all stakeholders, including patients. This is especially important in research involving artificial intelligence (AI), such as the VASCUL-AID project, a European collaboration aimed at creating predictive models for cardiovascular disease progression in patients with chronic symptomatic PAD. This study aimed to create a COS for patients with chronic symptomatic PAD for use in clinical and AI research. Methods: This COS was pre-registered in the Core Outcome Measures in Effectiveness Trials (COMET) database and was developed in line with the COMET Initiative recommendations. A longlist of PAD outcomes was formed based on outcomes identified from a systematic literature review and focus groups with patients and healthcare professionals (HCPs). Next, a Delphi study with patients and HCPs was conducted. The COS was finalised in an expert consensus meeting with key opinion leaders, patients, and patient representatives. Results: The longlist comprised 67 outcomes: 36 outcomes identified from a systematic literature review and 31 patient centred outcomes from the focus groups. In total, 153 HCPs and 92 patients participated in the Delphi study, with an overall participation rate of 85%. The Delphi study's 20 highest rated outcomes were discussed in the expert consensus meeting, attended by 21 HCPs, three patients, and two patient representatives. The final COS consists of 11 outcomes: death, myocardial infarction, major amputation, acute limb ischaemia, thromboembolic complications, disease progression, pain free walking distance, physical activity, health related quality of life, smoking cessation, and good communication by healthcare provider. Conclusion: This is the first COS for patients with chronic symptomatic PAD recommended for adoption in clinical and AI research.
AB - Objective: Current literature on patients with peripheral arterial disease (PAD) is heterogeneous and characterised by selective outcome reporting. A core outcome set (COS) is a list of essential outcomes based on expert consensus used to standardise clinical research, reflecting the needs of all stakeholders, including patients. This is especially important in research involving artificial intelligence (AI), such as the VASCUL-AID project, a European collaboration aimed at creating predictive models for cardiovascular disease progression in patients with chronic symptomatic PAD. This study aimed to create a COS for patients with chronic symptomatic PAD for use in clinical and AI research. Methods: This COS was pre-registered in the Core Outcome Measures in Effectiveness Trials (COMET) database and was developed in line with the COMET Initiative recommendations. A longlist of PAD outcomes was formed based on outcomes identified from a systematic literature review and focus groups with patients and healthcare professionals (HCPs). Next, a Delphi study with patients and HCPs was conducted. The COS was finalised in an expert consensus meeting with key opinion leaders, patients, and patient representatives. Results: The longlist comprised 67 outcomes: 36 outcomes identified from a systematic literature review and 31 patient centred outcomes from the focus groups. In total, 153 HCPs and 92 patients participated in the Delphi study, with an overall participation rate of 85%. The Delphi study's 20 highest rated outcomes were discussed in the expert consensus meeting, attended by 21 HCPs, three patients, and two patient representatives. The final COS consists of 11 outcomes: death, myocardial infarction, major amputation, acute limb ischaemia, thromboembolic complications, disease progression, pain free walking distance, physical activity, health related quality of life, smoking cessation, and good communication by healthcare provider. Conclusion: This is the first COS for patients with chronic symptomatic PAD recommended for adoption in clinical and AI research.
KW - Artificial intelligence
KW - Core outcome set
KW - Peripheral arterial disease
UR - https://www.scopus.com/pages/publications/105023672579
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105023672579&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/40992592
U2 - 10.1016/j.ejvs.2025.09.022
DO - 10.1016/j.ejvs.2025.09.022
M3 - Article
C2 - 40992592
AN - SCOPUS:105023672579
SN - 1078-5884
JO - European journal of vascular and endovascular surgery
JF - European journal of vascular and endovascular surgery
ER -